Washington University endocrine and oncologic surgeons have the largest experience in the world treating medullary thyroid carcinoma, a rare form of thyroid cancer.
Medullary thyroid carcinoma is the third most common type of thyroid cancer but only accounts for 5 to 8 percent of cases. Medullary cancer of the thyroid arises from parafollicular cells (C cells), which secrete an abnormal hormone. This is a distinction from papillary and follicular thyroid carcinomas, which originate in cells producing thyroid hormone. C cells produce calcitonin, which does not control metabolism as thyroid hormones do.
Medullary thyroid carcinoma can occur as an isolated condition or as part of the Multiple Endocrine Neoplasia Type 2 (MEN 2) syndromes.
Specialists who treat medullary thyroid carcinoma:
For patient appointments, call (314) 362-2280.